Expression of protease-activated receptors and tissue factor in human liver

被引:0
|
作者
Anne Rullier
Nathalie Senant
Walter Kisiel
Paulette Bioulac-Sage
Charles Balabaud
Brigitte Le Bail
Jean Rosenbaum
机构
[1] Université Victor Segalen Bordeaux 2,GREF/INSERM E362
[2] Université Victor Segalen Bordeaux 2,Department of Pathology,
[3] IFR 66,Department of Pathology
[4] CHU de Bordeaux,undefined
[5] Hôpital Pellegrin,undefined
[6] University of New Mexico School of Medicine,undefined
来源
Virchows Archiv | 2006年 / 448卷
关键词
Thrombin receptor; Tissue factor; Human liver; Immunohistochemistry; Liver neoplasm;
D O I
暂无
中图分类号
学科分类号
摘要
Thrombin, acting via protease-activated receptors (PARs), and tissue factor (TF) are involved in inflammation, tissue repair and tumorigenesis. Hepatocellular carcinomas (HCCs) usually complicate chronic liver diseases characterised by inflammation and fibrosis. The aim of this study was to describe the expression of PARs and TF in normal liver, cirrhosis and HCCs. We performed an immunohistochemical detection of PAR-1, PAR-3, PAR-4 and human TF in human tissue samples from 19 subnormal livers, 33 cirrhosis and 30 HCCs. PAR-1 was found on endothelial cells of sinusoids and larger vessels. In cirrhosis, spindle-shaped cells within septa and T lymphocytes were PAR-1 positive. A few PAR-1-positive tumour cells were found in 10% of HCCs. PAR-4 expression was restricted to macrophages, B lymphocytes and nerves. PAR-3 expression was rare. Unexpectedly, TF was expressed in 95% of normal livers and in 94% of cirrhosis but only in 50% of HCCs (p<0.001). Staining was mostly hepatocellular. No association existed between TF labelling and clinicopathological characteristics of HCCs. In conclusion, the pattern of expression of PARs is compatible with its role in chronic liver disease by promoting inflammation via immune cells and neurogenic stimulation. However, our data do not support a role for PARs or TF in HCC progression.
引用
收藏
页码:46 / 51
页数:5
相关论文
共 50 条
  • [31] Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis
    Lin, C.
    Borensztajn, K.
    Spek, C. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (04) : 597 - 607
  • [32] The role of tissue factor and protease-activated receptor 2 in endometriosis
    Lin, Min
    Weng, Huinan
    Wang, Xuefeng
    Zhou, Bing
    Yu, Ping
    Wang, Yifeng
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 68 (03) : 251 - 257
  • [33] PROTEASE-ACTIVATED RECEPTORS IN HEALTH AND DISEASE
    Peach, Chloe J.
    Edgington-Mitchell, Laura E.
    Bunnett, Nigel W.
    Schmidt, Brian L.
    PHYSIOLOGICAL REVIEWS, 2023, 103 (01) : 717 - 785
  • [34] Progress in the understanding of protease-activated receptors
    Gabazza, EC
    Taguchi, O
    Kamada, H
    Hayashi, T
    Adachi, Y
    Suzuki, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (02) : 117 - 122
  • [35] Protease-activated receptors: sentries for inflammation?
    Cocks, TM
    Moffatt, JD
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) : 103 - 108
  • [36] Endosomal Signaling by Protease-Activated Receptors
    Grimsey, Neil
    Lin, Huilan
    Trejo, JoAnn
    ENDOSOME SIGNALING, PT B, 2014, 535 : 389 - 401
  • [37] Pharmacological characterization of the protease-activated receptors in human erythroleukaemic cells
    Poucher, SM
    Freeman, S
    Heapy, CG
    Daniels, SM
    Cotton, R
    Giles, MB
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U72 - U72
  • [38] Role of protease-activated receptors in human skin fibrosis and scleroderma
    Cevikbas, Ferda
    Seeliger, Stephan
    Fastrich, Michaela
    Hinte, Heike
    Metze, Dieter
    Kempkes, Cordula
    Homey, Bernhard
    Steinhoff, Martin
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (01) : 69 - 71
  • [39] Thrombin signalling and protease-activated receptors
    Shaun R. Coughlin
    Nature, 2000, 407 : 258 - 264
  • [40] Protease-activated receptors in cardiovascular diseases
    Leger, Andrew J.
    Covic, Lidija
    Kuliopulos, Athan
    CIRCULATION, 2006, 114 (10) : 1070 - 1077